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Transplantation of livers from patients with familial amyloidotic
polyneuropathy undergoing orthotopic liver transplantation is
based on the normal functions of these livers, except for the
production of an abnormal protein that causes the disease,
which takes more than 20 years to become clinically apparent.
Given the shortage of cadaver grafts, domino liver transplanta-
tion has the potential to increase the offer to some selected
patients. The known experience amounts to little more than 80
cases. Domino liver transplantation has been a safe procedure
with all the advantages of living donor grafts. So far, the
disease has not shown up in any recipient, including the
longest surviving patient (4 years). Particularly in countries
where the disease is common, the potential to increase graft
offer may be significantly augmented through cooperation
between centers and better exploitation of technical possibili-
ties. The combination of split and domino has been reported
six times and may provide three to six transplants from only
one cadaver graft. Curr Opin Organ Transplant 2000, 5:69–73 © 2000
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Domino organ transplantation was probably mentioned
for the first time to describe the transplantation of a
heart graft retrieved from a patient undergoing a heart-
lung transplantation. The heart of this patient was
normal and was transplanted into a second patient with
end-stage cardiac dysfunction [1]. A similar procedure
was accomplished with the liver in 1991 [2], although in
this case the graft was procured from a liver recipient
who suffered brain death.
On October 26, 1995, for the first time, the whole liver
of a living patient with familial amyloidotic polyneu-
ropathy (FAP) receiving a cadaver graft was transplanted
into a man with isolated liver metastasis from a sigmoid
cancer. After our report of the first cases of this “sequen-
tial liver transplantation” [3,4], the procedure was soon
accepted [5,6,7•,8••] and became better known as
domino liver transplantation (DLTx).
Familial amyloidotic polyneuropathy is an autosomal
hereditary dominant disorder (linked to chromosome 18)
whose biochemical basis depends on the production,
almost exclusively by the liver, of an abnormal trans-
thyretin (TTR). There are several variants, the most
common being the TTR Met 30, in which the normal
valine is replaced by methionine. This mutant is typical
of all cases of the disease in Portugal, the country with
the highest incidence of FAP and where the disease was
first scientifically described [9]. Besides Portugal, FAP
patients are particularly concentrated in Sweden and
Japan, but rare cases are found almost all over the world.
Although this review is restricted to the use of livers
from FAP Met 30 patients, this domino procedure will
be cited simply as DLTx.
Liver transplantation was first used to treat FAP in 1990
and remains the only hope for these patients [10–13]. A
total of 368 FAP patients who had undergone transplants
had been reported to the FAP World Transplantation
Registry as of June 1999 [14], but we believe that more
than 500 have already undergone transplant worldwide.
The livers of FAP patients are anatomically normal,
having only one functional abnormality—the production
of the abnormal TTR. Thus it is appealing to use the
livers of FAP patients as living donor grafts for selected
patients with other liver diseases, under well-defined
conditions. Although the contribution of procured grafts
from cadavers of patients who have previously under-
gone transplants has been and is expected to remain
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extremely small [15], DLTx using organs from FAP
patients may have the potential to significantly decrease
organ shortage, mainly in countries where this disease is
commonly found.
Rationale
Even among the population groups with the earliest onset
of symptoms, FAP never becomes a clinical entity before
the patient is 20 years old (later for most patients). The
progression to death takes 10 to 15 years and the disease
usually remains tolerable for the first half of this period.
It must be assumed that FAP may develop in nongenet-
ically affected recipients of DLTx. Indeed, the abnor-
mal protein appears in the blood of the recipients
shortly after transplantation. It is highly probable that
the disease, if it develops, will follow the same course as
in the genetically affected patients. This means that
more than 25 years would elapse without relevant symp-
toms. So, for a 50-year-old patient, with a nonresectable
malignancy of the liver, the opportunity that he or she
otherwise would not have (to receive a transplant from
the waiting list for cadaver grafts) seems an adequate
indication. This was our original proposal for the stra-
tegy of DLTx [4] and remains the most unquestionable
indication. Indeed, the offer of a life expectancy of 25
years or more for such a patient would be a blessing,
provided the transplant itself will remain functioning
throughout this period and the tumor does not recur.
The use of FAP liver grafts bears the great advantages
of any living donor graft: excellent preharvesting hemo-
dynamic conditions, few minutes of warm ischemia
before University of Wisconsin (UW) hypothermic
perfusion (average 3 minutes, in our experience), very
short total ischemia time, and excellent initial function.
Ethical principles
The most important ethical principle concerns the
informed consent of the domino recipient, including the
need to underscore that the patient may develop paramy-
loidosis if he or she survives long enough. The patient
must be assured that, should the FAP appear, he or she
would have an opportunity to receive a non-FAP cadaver
graft. According to Portuguese law and to our guiding
ethical principles, there is no need to inform the FAP
donor about the use of his or her liver in another patient.
However, all our patients have previously been informed
about the procedure. They were happy to know that their
organs could be of some benefit to other patients, whom
they met later in the ward. Also, the FAP patients must be
assured that the technical demands of the hepatectomy for
a domino will not impose on them any unusual risks.
Indications
Our original aim was to use the domino strategy for
nonresectable hepatocellular cancers or neuroendocrine
tumors (excluding the first patient, who had liver metas-
tasis from a sigmoid cancer). However, the pressure
from a long waiting list with other pathologies and high
risk patients of over 50 years led us to offer the domino
technique in selected noncancer cases, mainly to
patients with hepatitis B and C or alcoholic cirrhosis.
A consensus report of the Hospital of the University of
Coimbra Ethical Committee in 1994 supported our
trend toward a flexible attitude in view of some of these
patients. Thus, in December 1996, we implanted an
FAP liver graft into a patient with alcoholic cirrhosis.
Thus far we have performed 13 DLTxs with FAP grafts
in patients without malignancy. In two extremely critical
situations, a third cadaver transplant was unanimously
excluded but a domino as a third transplant in these two
young patients was promptly accepted (one of them, a
28-year-old-man, is alive and well; the other died of
continuous sepsis).
The indications for domino procedures must take into
account many factors, including age, risks, probability of
recurrences, global prognosis, and priorities in the candi-
date lists. In the special case of Portugal, all the waiting
lists in the four liver transplant centers include a large
number of FAP patients eagerly awaiting transplanta-
tion, whose deteriorating condition may soon preclude
the only hope of halting the progression to death. A sort
of “competition” between FAP and non-FAP candi-
dates exists and the domino may minimize this dilemma
in a nonnegligible number of cases. The FAP cases in
our transplant experience represent 33% of all the
patients undergoing transplantation; this percentage is
even higher in the other transplant centers of Portugal.
In our total experience of 27 DLTxs (Hospital of the
University of Coimbra), the dominos amount to 9% of
all patients undergoing transplantation.
The patient survival rate for orthotopic liver transplanta-
tion at 10 years in European centers is about 60%. The
survival rate at 30 years is not yet known, but it seems
reasonable to presume that by that time, most patients
who received a domino FAP graft at the age of 50 will
be dead from causes other than paramyloidosis (includ-
ing the harmful effects of immunosuppression).
Main technical points and contribution to
increased graft offer
Hepatectomy in the FAP patient must be carried out
under conditions such that the liver may be safely used
as a graft in another patient. The hepatectomy must
include the retrohepatic vena cava and, as a conse-
quence, the use of an external venovenous bypass has
been the rule in our experience, even if the FAP liver is
to be implanted as a piggy-back. The FAP patients are
hemodynamically rather fragile [16–19] and have no
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portal collateral circulation; thus, in our view, the
venovenous bypass affords total safety, although there
are several reports [8••,20] of procedures performed
without venous bypass and no problems were reported.
We think that the vena cava–preserving hepatectomy
in FAP is inadequate for using the liver as a whole
graft. Despite our experience of more than 200 hepate-
ctomies with preservation of the vena cava in the recip-
ient (including most FAP patients), the procedure is
substantially more difficult than hepatectomy includ-
ing the vena cava. The difficulties would be greater if
the liver were used as a graft; the quality of the graft
could be jeopardized (some accessory hepatic veins
must be ligated) and its implantation would be enor-
mously more difficult, if not impossible. The difficul-
ties and the inherent risks would be higher for the FAP
patient.
In some hepatectomies for DLTx, a transdiaphragmatic
dissection of the vena cava may be advisable to keep
good segments of that vein both with the graft and with
the FAP patient. As we noted in our first reports [3,4],
the division of the diaphragmatic fibrotic ring around
the vena cava requires particular care, but it is a safe
step for an experienced surgeon. However, dividing the
suprahepatic segment of the vena cava just flat to the
liver may spare this step and would not preclude an
adequate implantation. In this case and if a classic
implantation is performed, the shortness or even the
absence of the segment of the suprahepatic vena cava in
the graft may be overcome with a venous graft exten-
sion, on the back table. This vena cava graft may be
obtained from the infrahepatic vena cava of the same
graft or from a cadaver. We have performed this veno-
plasty three times, without complications.
The division of the hilar structures in the FAP patient
must respect the best conditions for excellent anastomo-
sis to the corresponding structures of the cadaver graft
that the patient is going to receive. The surgeon should
examine this graft before surgery to perfect the proce-
dure and allow for greater technical flexibility.
The domino graft may be implanted in the classic
fashion or as a piggy-back. We consider the classic tech-
nique more appropriate for patients with tumors, espe-
cially when they are sited not far from the vena cava; for
benign cases we always prefer the piggy-back technique
without external venovenous bypass.
The use of DLTx has, so far, contributed 75 grafts in
the seven centers (Table 1) that replied to a short ques-
tionnaire aimed at updating the international experience
on this subject. However, if we add some known cases
from centers that did not reply, surely more than 80
cases have been performed. This contribution to
increased graft offer is small when compared with the
number of liver transplants performed in each center.
Three ways of increasing that contribution may be
envisaged: broadening the field of indications; combin-
ing the domino with splitting; and intensifying coopera-
tion between centers. The combination of all three atti-
tudes would provide the best chances of optimum
sharing.
At the moment FAP grafts have been used mainly in
benign cases and malignant liver pathologies, but
presumably the number of benign cases will increase
in the future, although paramyloidosis could unexpect-
edly show up early in a single or in several domino-
transplanted patients. This has not happened so far in
any patient, including one patient followed up for 4
years and three patients followed up for 3 years at the
Hospital of the University of Coimbra. The clinical
assessment and neurologic evaluation of these patients
continue to show no signs of the disease. In three of
these domino-transplanted patients, cutaneous biop-
sies were performed 2.5 years after transplantation and
no amyloid deposits were found. This leads us to plan
new biopsies no sooner than 5 years after the domino
transplants.
The combination of the split with the domino has been
accomplished at least six times [21••,22,23], allowing
three transplants (Fig. 1), starting with only one cadaver
graft. In one of these combinations [23], the split was
done in situ in the FAP patient.
The furthest extension of this combined procedure will
be splitting a cadaver graft, using the two splits in two
FAP patients and then splitting the two FAP livers to
perform four dominos. Thus, starting with one cadaver
graft, six transplants would be accomplished (Fig. 2).
However, it is hardly conceivable that any transplant
center would meet the logistics (staff and facilities)
required for such a long, difficult task, at least routinely.
Therefore the combination of split and domino may
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*Three of these procedures were split plus domino. †Two of these









































Table 1. Use of domino liver transplantation in seven centers
provide three to six transplants, but so far only three
transplants have been achieved in each procedure
already reported.
In our view, the best chances for optimum exploitation
of organ offering and sharing when using the domino
procedure lie in cooperation between centers. In a
small center like ours (with limited staff and facilities)
the combination of split and domino is an exhausting
achievement. But splitting the cadaver graft and locally
using one of the splits while sending the other to
another center to receive from it, hours later, an FAP
graft, is a much more acceptable challenge. This coop-
eration will substantially diminish the stress on the
staff and, in our case, may allow the reuse of the same
operating room. With good coordination, it allows
better selection of the recipients, keeps the ischemia
times shorter, and may increase the opportunities for a
triple transplant from a single cadaver graft. This coop-
eration may increase the number of transplants and
may become a significant contribution in countries
with an important number of FAP candidates awaiting
liver transplantation, along with the usual non-FAP
candidates.
International experience
So far, only a limited number of DLTx cases have been
reported. From the restricted questionnaire that we
have previously mentioned, it may be stated that all
centers followed the same general guiding principles for
the 75 dominos reported, most of them performed on
patients older than 50 years with malignancies. We are
sure that the procedure has been performed in more
than 80 cases. Repeated neurologic assessments and
biopsies have been performed showing no signs of FAP
disease or deposits of amyloid in skin and nerves at 2.5
years after transplantation (the longest follow-up, at the
Hospital of the University of Coimbra). There have
been no deaths. The incidence of relevant complica-
tions in the FAP patients, ascribable to the specific tech-
nical problems of the domino procedures, was very small
(only four reported and some doubtfully related to the
technical peculiarities of the domino procedure).
Conclusions
Domino liver transplantation with FAP livers is an inno-
vative strategy that is contributing to increased liver
graft offer. It is indicated in patients whose age or prog-
nosis would cast doubts on the use of a cadaver graft or
would delay or even preclude their receiving transplants
from waiting lists with higher priorities. The procedure
has been shown to be safe both for the FAP donor and
the recipient and it has all the advantages of living
donor grafts. In communities where the disease is
commonly found, the contribution for increasing the
number of transplants may become significant. The
combination of split and domino may contribute to a
further increase in the number of transplants. Good
cooperation between different centers may overcome
the difficulties for optimum use of this strategy. It is
expected that the appearance of FAP disease in the
domino recipient will not occur earlier than than 20
years after DLTx. Periodic evaluation of DLTx recipi-
ents is required.
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*If split, 4 transplants may be performed. †In the bench or in situ. FAP, familial
amyloidotic polyneuropathy.
Figure 2. Strategy for six transplants, starting from one
cadaver graft
Split + domino

















FAP, familial amyloidotic polyneuropathy.
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